Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Journal of Cancer Research and Clinical Oncology|April 23, 2014
Active surveillance for metastatic or recurrent renal cell carcinomaInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
International Journal of Clinical and Experimental Pathology|January 1, 2015
VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patientsSang Hoon Song, In Gab Jeong, Dalsan You, et al.
Investigational New Drugs|October 21, 2011
Phase II study of a cremophor-free, polymeric micelle formulation of paclitaxel for patients with advanced urothelial cancer previously treated with gemcitabine and platinumJae-Lyun Lee, Jin-Hee Ahn, Se Hoon Park, et al.
Cancer Research and Treatment|July 8, 2020
Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in KoreaSahyun Pak, Dalsan You, In Gab Jeong, et al.
Journal of Korean Medical Science|September 3, 2010
Efficacy of dendritic cells matured early with OK-432 (Picibanil), prostaglandin E2, and interferon-alpha as a vaccine for a hormone refractory prostate cancer cell lineChanghee Yoo, Hyun-Ah Do, In Gab Jeong, et al.
BMC Cancer|March 11, 2018
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control studyMyong Kim, Cheryn Song, In Gab Jeong, et al.
Cancer Chemotherapy and Pharmacology|March 18, 2015
Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitorInkeun Park, Jae-Lyun Lee, Jin-Hee Ahn, et al.
Korean Journal of Urology|March 13, 2015
Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: a Korean nationwide health insurance database studyJuhyun Park, Young Ju Lee, Jeong Woo Lee, et al.
The Journal of Urology|June 25, 2013
Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomiesIn Gab Jeong, Ju Hyun Lim, Dalsan You, et al.
Cancer Chemotherapy and Pharmacology|December 22, 2015
Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinomaDong-Hoe Koo, Inkeun Park, Jin-Hee Ahn, et al.
Pageof 20